NewsApril 20, 2021NICE says yes to Novartis’ multiple sclerosis therapy Kesimpta Share XNICE says yes to Novartis’ multiple sclerosis therapy Kesimptahttps://pharmaphorum.com/news/nice-says-yes-to-novartis-multiple-sclerosis-therapy-kesimpta/
NewsApril 19, 2021EMA starts review of GSK/Vir COVID-19 antibody Share XEMA starts review of GSK/Vir COVID-19 antibodyhttps://pharmaphorum.com/news/ema-starts-review-of-gsk-vir-covid-19-antibody/
NewsMarch 31, 2021Novartis builds radio-oncology pipeline with iTheranostics deal Share XNovartis builds radio-oncology pipeline with iTheranostics dealhttps://pharmaphorum.com/news/novartis-builds-radio-oncology-pipeline-with-itheranostics-deal/
NewsMarch 29, 2021CHMP backs Celltrion’s regdanvimab antibody for COVID-19 Share XCHMP backs Celltrion’s regdanvimab antibody for COVID-19https://pharmaphorum.com/news/chmp-backs-celltrions-regdanvimab-antibody-for-covid-19/
NewsMarch 19, 2021NICE backs ovarian cancer and multiple myeloma combination drugs Share XNICE backs ovarian cancer and multiple myeloma combination drugshttps://pharmaphorum.com/news/nice-backs-ovarian-cancer-and-multiple-myeloma-combination-drugs/
NewsMarch 11, 2021J&J’s COVID-19 shot backed for emergency use in EU Share XJ&J’s COVID-19 shot backed for emergency use in EUhttps://pharmaphorum.com/news/jjs-covid-19-shot-backed-for-emergency-use-in-eu/
NewsMarch 8, 2021EMA backs emergency use of Lilly’s COVID antibodies Share XEMA backs emergency use of Lilly’s COVID antibodieshttps://pharmaphorum.com/news/ema-backs-emergency-use-of-lillys-covid-antibodies/
NewsMarch 1, 2021GSK hits trouble with Trelegy as EU regulators block asthma indication Share XGSK hits trouble with Trelegy as EU regulators block asthma indicationhttps://pharmaphorum.com/news/gsk-hits-trouble-with-trelegy-as-eu-regulators-block-asthma-indication/
NewsFebruary 4, 2021UK reaches 10 million landmark with COVID-19 vaccination programme Share XUK reaches 10 million landmark with COVID-19 vaccination programmehttps://pharmaphorum.com/news/uk-reaches-10-million-landmark-with-covid-19-vaccination-programme/
NewsFebruary 1, 2021CHMP clears way for EU approval of Novartis’ MS drug Share XCHMP clears way for EU approval of Novartis’ MS drughttps://pharmaphorum.com/news/chmp-clears-way-for-eu-approval-for-novartis-ms-drug/
NewsJanuary 29, 2021EMA approves AZ’s COVID-19 vaccine – including for over-65s Share XEMA approves AZ’s COVID-19 vaccine – including for over-65shttps://pharmaphorum.com/news/ema-approves-azs-covid-19-vaccine-including-for-over-65s/
NewsJanuary 12, 2021EMA says AstraZeneca’s COVID-19 shot could be approved on 29 January Share XEMA says AstraZeneca’s COVID-19 shot could be approved on 29 Januaryhttps://pharmaphorum.com/news/ema-says-astrazenecas-covid-19-shot-could-be-approved-on-29-january/
